Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New Criteria for Pediatric Sepsis: A Phoenix Rising.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2024
Same author

Molecular Epidemiology of <i>Clostridioides difficile</i> Colonization in Families With Infants.

Open forum infectious diseases·2024
Same author

The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium.

Vaccines·2023
Same author

Adjunctive Diagnostic Studies Completed Following Detection of Candidemia in Children: Secondary Analysis of Observed Practice From a Multicenter Cohort Study Conducted by the Pediatric Fungal Network.

Journal of the Pediatric Infectious Diseases Society·2023
Same author

VACCELERATE Site Network: Real-time definition of clinical study capacity in Europe.

Vaccine·2023
Same author

50 Years Ago in TheJournalofPediatrics: Acute Epiglottitis: To Trach or Not to Trach.

The Journal of pediatrics·2023

Related Experiment Video

Updated: May 13, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Clostridium difficile Infection in children.

Julia Shaklee Sammons1, Philip Toltzis, Theoklis E Zaoutis

  • 1Department of Pediatrics, University of Pennsylvania School of Medicine, PA, USA. sammonsj@email.chop.edu

JAMA Pediatrics
|March 6, 2013
PubMed
Summary
This summary is machine-generated.

Clostridium difficile infection (CDI) is a growing concern in children, with changing epidemiology and increased severity. This review covers pediatric CDI incidence, risk factors, special populations, diagnosis, and management.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Related Experiment Videos

Last Updated: May 13, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Area of Science:

  • Pediatric Infectious Diseases
  • Gastroenterology
  • Epidemiology

Background:

  • Clostridium difficile infection (CDI) is a leading cause of health care-associated diarrhea in adults.
  • Recent epidemiological shifts include a hypervirulent strain and increased community-acquired infections.
  • CDI is increasingly recognized as a significant pathogen in pediatric populations.

Purpose of the Study:

  • To review current knowledge on the incidence and epidemiology of CDI in children.
  • To highlight risk factors, special pediatric populations (e.g., IBD, cancer), diagnosis, and management of pediatric CDI.
  • To identify future research directions for pediatric CDI.

Main Methods:

  • Literature review of recent studies on pediatric Clostridium difficile infection.
  • Synthesis of data on incidence, epidemiology, risk factors, and clinical outcomes.
  • Analysis of diagnostic and management strategies in pediatric populations.

Main Results:

  • CDI is an emerging and important pathogen in children, with evolving epidemiology.
  • Specific risk factors and increased disease severity are noted in certain pediatric groups.
  • Knowledge gaps exist in diagnosis and management, necessitating further research.

Conclusions:

  • Pediatric CDI requires focused attention due to changing patterns and potential severity.
  • Further research is crucial to optimize diagnosis, management, and prevention strategies for children.
  • Understanding CDI in special pediatric populations is essential for improved patient outcomes.